Literature DB >> 6721783

Dermatofibrosarcoma protuberans of the head and neck.

L Barnes, J A Coleman, J T Johnson.   

Abstract

To elucidate the natural history of dermatofibrosarcoma protuberans of the head and neck, 17 cases were reviewed and compared with 92 others contained within the English literature. The prototypic case is seen as a firm, solitary, slowly enlarging, asymptomatic, cutaneous nodule between 2 and 5 cm in size and of two years' duration. It is more common in men and in persons aged between 30 and 40 years. The scalp and neck-supraclavicular fossa are the most common sites, accounting for half of the cases. Approximately 50% to 75% of the patients experience local recurrence after initial surgery and, of these, half to three fourths manifest within three years of treatment. Metastases, seen in no more than 6% of all cases, are almost invariably preceded by two or more local recurrences and occur primarily through the bloodstream to the lungs and bones and less often to regional lymph nodes. Prognostic factors, differential diagnosis, and histogenesis are included.

Entities:  

Mesh:

Year:  1984        PMID: 6721783     DOI: 10.1001/archotol.1984.00800320052012

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  13 in total

1.  Pedunculated Nodules as a Variant of Dermatofibrosarcoma Protuberans.

Authors:  Min Jung Kim; Min Seok Hur; Byung Gon Choi; Soo Young Kim; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2016-09-30       Impact factor: 1.444

Review 2.  Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck.

Authors:  Nikolaos Angouridakis; Panagiotis Kafas; Waseem Jerjes; Stefanos Triaridis; Tahwinder Upile; Georgios Karkavelas; Angelos Nikolaou
Journal:  Head Neck Oncol       Date:  2011-02-04

3.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

Review 4.  A Review of the Global Guidelines on Surgical Margins for Nonmelanoma Skin Cancers.

Authors:  Amanda F Nahhas; Chase A Scarbrough; Shannon Trotter
Journal:  J Clin Aesthet Dermatol       Date:  2017-04

5.  Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans--a case report.

Authors:  Doreen Lemm; Lars-Olof Muegge; Klaus Hoeffken; Talal Aklan; Thomas Mentzel; Michael Thorwarth; Stefan Schultze-Mosgau
Journal:  Oral Maxillofac Surg       Date:  2008-08-27

6.  Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.

Authors:  Piotr Rutkowski; Agnieszka Wozniak; Tomasz Switaj
Journal:  Sarcoma       Date:  2011-03-30

7.  Dermatofibrosarcoma protuberans diagnosed by a single biopsy.

Authors:  Kristian Bakke Arvesen; Carsten Sauer Mikkelsen; Torben Steiniche; Birgitte Stausbøl-Grøn
Journal:  Dermatol Reports       Date:  2012-07-26

8.  Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.

Authors:  Francois G Kamar; Victor F Kairouz; Alain N Sabri
Journal:  Clin Sarcoma Res       Date:  2013-04-04

Review 9.  Dermatofibrosarcoma protuberans treated by micrographic surgery.

Authors:  A Ah-Weng; J R Marsden; D S A Sanders; R Waters
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

10.  Considerations for tissue expansion in the management of massive dermatofibrosarcoma protuberans of the head and neck.

Authors:  Austin M Badeau; Mark Granick; Frederic W-B Deleyiannis
Journal:  Eplasty       Date:  2013-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.